Belgium· BE-AMP-SAM463840-00
Daklinza 60 mg
A daclatasvir product containing daclatasvir dihydrochloride, registered in Belgium by Bristol-Myers Squibb Pharma.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Daclatasvir Dihydrochloride
- Manufacturer
- Bristol-Myers Squibb Pharma
- Country
- Belgium (BE)
- ATC code
- J05AX14
- ATC class
- Daclatasvir
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 2
- be_apb7712847
- be_apb3189651
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
124 interactions on record for daclatasvir.
Graded by severity as the source publishes them — 21 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Daclatasvir · interactions on record
124 records
- 21 severe
- 97 moderate
- 5 minor
Most severe, free to view
- EluxadolineA07DA06severe
- EdoxabanB01AF03severe
- DexamethasoneH02AB02severe
- KetoconazoleH02CA03severe
1 more interaction with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Daclatasvir in 3 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b25b0637-1699-4c3b-9ed2-48a33ad94b5f GET /v1/drugs/b25b0637-1699-4c3b-9ed2-48a33ad94b5f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Film-coated tablet",
"source": "afmps",
"status": "REVOKED",
"name_en": "Daklinza 60 mg",
"name_fr": "Daklinza 60 mg",
"name_nl": "Daklinza 60 mg",
"amp_code": "SAM463840-00",
"strengths": [
"60.0000",
"60.0000"
],
"pack_count": 2,
"substances": [
"Daclatasvir Dihydrochloride",
"Daclatasvir"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Daclatasvir",
"authorisation_numbers": [
"EU/1/14/939/004",
"EU/1/14/939/003"
]
}See everything about daclatasvir.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.